Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens (original) (raw)

Norovirus: Targets and tools in antiviral drug discovery

Biochemical Pharmacology, 2014

Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance

Pharmaceuticals

Computational studies on the interaction of ABO-active saccharides with the norovirus VA387 capsid protein can explain experimental binding data

Göran Larson, Per-Georg Nyholm

Journal of Computer-Aided Molecular Design, 2010

View PDFchevron_right

An in silico virtual screening study for the design of norovirus inhibitors: fragment-based molecular docking and binding free energy calculations

Magnus Lundborg

Carbohydrate Research, 2013

View PDFchevron_right

Identification of compelling inhibitors of human norovirus 3CL protease to combat gastroenteritis: A structure-based virtual screening and molecular dynamics study

Nawal Helmi

Frontiers in Chemistry

View PDFchevron_right

Human Noroviruses' Fondness for Histo-Blood Group Antigens

Bishal Singh

Journal of Virology, 2014

View PDFchevron_right

Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity

Frederick Neill

Nature Communications

View PDFchevron_right

Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease

Gerald Lushington

European journal of medicinal chemistry, 2018

View PDFchevron_right

High-Resolution X-Ray Structure and Functional Analysis of the Murine Norovirus 1 Capsid Protein Protruding Domain

John Rubin

Journal of Virology, 2010

View PDFchevron_right

Targeting Norovirus Infection—Multivalent Entry Inhibitor Design Based on NMR Experiments Dedicated to Professor Heinz Rüterjans on the occasion of his 75th birthday

Francisco Parra

View PDFchevron_right

Unveiling of Pyrimidindinones as Potential Anti-Norovirus Agents—A Pharmacoinformatic-Based Approach

Oluwakemi Ebenezer

Molecules, 2022

View PDFchevron_right

Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease

Gerald Lushington

Journal of Medicinal Chemistry, 2020

View PDFchevron_right

Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors

Gerald Lushington

European Journal of Medicinal Chemistry, 2016

View PDFchevron_right

Crystal Structure of Inhibitor-Bound GII.4 Sydney 2012 Norovirus 3C-Like Protease

Kurt Krause

Viruses

View PDFchevron_right

In Silico Screening and Molecular Dynamics Simulation Studies in the Identification of Natural Compound Inhibitors Targeting the Human Norovirus RdRp Protein to Fight Gastroenteritis

Farah Anjum

International Journal of Molecular Sciences

View PDFchevron_right

In crystallo-screening for discovery of human norovirus 3C-like protease inhibitors

Jingxu Guo

Journal of Structural Biology: X, 2020

View PDFchevron_right

Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives

Lijuan Yuan

Future Virology, 2015

View PDFchevron_right

GII.4 Human Norovirus: Surveying the Antigenic Landscape

Ralph Baric

Viruses

View PDFchevron_right

Characterization of a novel conformational GII.4 norovirus epitope: Implications in norovirus-host interactions

Javier Buesa

Journal of Virology, 2016

View PDFchevron_right

Targeting Norovirus Infection-Multivalent Entry Inhibitor Design Based on NMR Experiments

Julie Guiard

Chemistry - A European Journal, 2011

View PDFchevron_right

More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules

David J Rowlands

Nature Structural & Molecular Biology, 2014

View PDFchevron_right

Structural Basis for Broad Detection of Genogroup II Noroviruses by a Monoclonal Antibody That Binds to a Site Occluded in the Viral Particle

Makoto Yamazaki

Journal of Virology, 2012

View PDFchevron_right

The P Domain of Norovirus Capsid Protein Forms a Subviral Particle That Binds to Histo-Blood Group Antigen Receptors

Ming Tan

Journal of Virology, 2005

View PDFchevron_right

Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses

Gabriela Alvarado

Nature Communications, 2021

View PDFchevron_right

Molecular Details of the Recognition of Blood Group Antigens by a Human Norovirus as Determined by STD NMR Spectroscopy

Francisco Parra

View PDFchevron_right

Structure of human enterovirus 71 in complex with a capsid-binding inhibitor

Moh Yap

2013

View PDFchevron_right

Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus

Mark Von Itzstein

Glycoconjugate Journal, 2006

View PDFchevron_right

Noroviral P particle: Structure, function and applications in virus–host interaction

Intan Less

Virology, 2008

View PDFchevron_right

Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C

Naemi Welter

PLOS Biology

View PDFchevron_right

Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope

Taylor Jones, Eric Donaldson

Journal of virology, 2014

View PDFchevron_right

Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens (original) (raw)

Related papers